Cellectis SA (CLLS)
2.99
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
3.05
+0.06
(+2.01%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly): 84.70M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 84.70M |
September 30, 2023 | 76.12M |
June 30, 2023 | 96.56M |
March 31, 2023 | 113.74M |
December 31, 2022 | 117.97M |
September 30, 2022 | 136.64M |
June 30, 2022 | 168.93M |
March 31, 2022 | 191.04M |
December 31, 2021 | 221.29M |
September 30, 2021 | 237.97M |
June 30, 2021 | 275.86M |
March 31, 2021 | 261.93M |
December 31, 2020 | 283.80M |
September 30, 2020 | 290.37M |
June 30, 2020 | 307.61M |
March 31, 2020 | 331.84M |
December 31, 2019 | 315.12M |
September 30, 2019 | 340.64M |
June 30, 2019 | 363.82M |
March 31, 2019 | 391.15M |
December 31, 2018 | 409.30M |
September 30, 2018 | 430.65M |
June 30, 2018 | 447.73M |
March 31, 2018 | 255.32M |
December 31, 2017 | 264.87M |
Date | Value |
---|---|
September 30, 2017 | 282.40M |
June 30, 2017 | 267.87M |
March 31, 2017 | 269.24M |
December 31, 2016 | 272.80M |
September 30, 2016 | 284.50M |
June 30, 2016 | 283.49M |
March 31, 2016 | 277.78M |
December 31, 2015 | 287.42M |
September 30, 2015 | 269.27M |
June 30, 2015 | 272.61M |
March 31, 2015 | 283.59M |
December 31, 2014 | 73.92M |
June 30, 2014 | 28.13M |
December 31, 2013 | 3.784M |
June 30, 2013 | 53.89M |
June 30, 2013 | 53.89M |
December 31, 2012 | 69.90M |
June 30, 2012 | 87.63M |
December 31, 2011 | 37.02M |
December 31, 2010 | 49.85M |
June 30, 2010 | 59.70M |
June 30, 2010 | 59.70M |
December 31, 2009 | 64.79M |
June 30, 2009 | 43.09M |
June 30, 2009 | 43.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
76.12M
Minimum
Sep 2023
363.82M
Maximum
Jun 2019
221.89M
Average
237.97M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Biophytis SA | -4.264M |
DBV Technologies SA | 140.19M |
Genfit SA | 75.11M |
Edap TMS SA | 62.92M |
Adaptimmune Therapeutics PLC | 39.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 334.27M |
Total Liabilities (Quarterly) | 249.58M |
Debt to Equity Ratio | 0.3968 |
Current Ratio | 1.502 |
Net Debt Paydown Yield | -0.77% |